Novo Nordisk A/S (LON:0TDD)
London · Delayed Price · Currency is GBP · Price in USD 49.35
+0.55 (1.13%)
At close: Nov 28, 2025
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 165.21 billion as of November 28, 2025. Its market cap has decreased by -55.31% in one year.
Market Cap
165.21B
Enterprise Value
173.26B
Revenue
36.88B
Ranking
n/a
PE Ratio
13.62
Stock Price
49.35
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 4.46B to 165.21B, an increase of 3,603.93%. That is a compound annual growth rate of 13.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 165.21B | -46.41% |
| Dec 30, 2024 | 308.32B | -14.91% |
| Dec 29, 2023 | 362.35B | 43.42% |
| Dec 30, 2022 | 252.66B | 33.68% |
| Dec 30, 2021 | 189.00B | 57.73% |
| Dec 30, 2020 | 119.83B | 15.27% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.70B |
| HSBC Holdings | 183.50B |
| Shell | 160.14B |
| Unilever | 113.13B |
| British American Tobacco p.l.c. | 96.16B |
| Rio Tinto Group | 92.26B |
| Rolls-Royce Holdings | 89.45B |
| GSK plc | 71.96B |